Macrolide resistance phenotypes and mechanisms of resistance in Streptococcus pyogenes in La Rioja, Spain. (Q54069089)

24 May 2018

title

Macrolide resistance phenotypes and mechanisms of resistance in Streptococcus pyogenes in La Rioja, Spain. (English)

1 reference

24 May 2018

main subject

Streptococcus pyogenes

object named as

Streptococcus pyogenes

1 reference

4

1 reference

24 May 2018

Carmen Torres

5

1 reference

24 May 2018

author name string

Portillo A

1

1 reference

24 May 2018

Lantero M

2

1 reference

24 May 2018

Gastañares MJ

3

1 reference

24 May 2018

publication date

1 October 1999

1 reference

24 May 2018

International Journal of Antimicrobial Agents

published in

1 reference

24 May 2018

volume

13

1 reference

24 May 2018

issue

2

1 reference

24 May 2018

page(s)

137-140

1 reference

24 May 2018

Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Different erythromycin resistance mechanisms in group C and group G streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Genetic manipulation of pathogenic streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy. The Italian Surveillance Group for Antimicrobial Resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Erythromycin resistance in group A beta hemolytic streptococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Emergence of erythromycin-resistant, clindamycin-susceptible Streptococcus pyogenes isolates in Madrid, Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Erythromycin resistance of Streptococcus pyogenes in Madrid.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

A survey of susceptibility to erythromycin amongst Streptococcus pyogenes isolates in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

High incidence of erythromycin-resistant Streptococcus pyogenes in Monza (North Italy) in untreated children with symptoms of acute pharyngo-tonsillitis: an epidemiological and molecular study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. The Italian Surveillance Group for Antimicrobial Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Resistance to Erythromycin in Group A Streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Erythromycin-resistant Streptococcus pyogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from out-patients in the USA

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

In vitro susceptibility of recent North American group A streptococcal isolates to eleven oral antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Survey of macrolide resistance phenotypes in Swedish clinical isolates of Streptococcus pyogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Clonal spread of group A streptococcus with the new type of erythromycin resistance. Finnish Study Group for Antimicrobial Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

10.1016/S0924-8579(99)00104-1

Identifiers

DOI

1 reference

24 May 2018

PubMed ID

10595574

1 reference

24 May 2018